Recombinant protein advancements revolutionize assay development
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
The cobas c 703 and cobas ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory workflows and advance patient care
Provides an automated, functionally closed approach to help address variability and support more reliable, consistent manufacturing outcomes
Forge Editing is a technique which uses no CRISPR proteins, but still benefits from the reprogrammability allowed by an RNA targeting region
New strategies pair high-performance chromatography with digital tools to tackle persistent pollutants
SpectrAline™ Cartridges, an MRR‑optimized preconcentration solution delivering higher sensitivity, improved sample loading, and reliable analysis of complex matrices
New imaging model in the PerkinElmer Spotlight Aurora family, the Aurora-I, brings powerful smart adaptive IR imaging capabilities to FTIR microscopy analysis
Dual zone mass spectrometry for fusion fuel analysis and vacuum diagnostics
Enables expression of active G-protein coupled receptors in 48 hours
The partnership will combine ABK's pioneering device technology with MURR's proven capabilities in isotope production and research excellence
Collaboration delivers an automated, high-plex molecular testing workflow on Hamilton liquid handling workstations
Integrating Stratech Scientific with Cambridge Bioscience will bring together two complementary portfolios, creating greater choice for UK life science researchers